Literature DB >> 22748017

A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein.

G G Alvarez1, E Sabri, D Ling, D W Cameron, G Maartens, D Wilson.   

Abstract

SETTING: Improved diagnostic algorithms for sputum smear-negative tuberculosis (SNTB) are needed to address the dramatic increase in SNTB in regions with high human immunodeficiency virus (HIV) prevalence.
OBJECTIVE: To determine whether the addition of C-reactive protein (CRP) to a prediction model using simple clinical criteria improves the diagnosis of SNTB among mostly antiretroviral-naïve adult HIV TB suspects in an out-patient setting.
DESIGN: A multiple logistic regression model was derived from a database of 228 HIV patients to predict the risk of SNTB using data from a previous prospective study.
RESULTS: The derived model demonstrated that male sex, night sweats, fever, low body mass index and anemia increased the probability of having SNTB. CRP improved the accuracy of the model (without CRP, area under the curve [AUC] 0.75, 95%CI 0.68-0.81 vs. model with CRP, AUC 0.81, 95%CI 0.76-0.87, P = 0.0014) to predict SNTB. Using reclassification tables, CRP correctly reclassified 27.9% of the patients (net reclassification improvement, P = 0.0005) into higher or lower risk categories. The strongest effect was seen in the reclassification improvement among patients with no TB, which was 20.6% (P = 0.0023).
CONCLUSION: CRP improved the performance of the prediction model in the diagnosis of SNTB in HIV patients, and may play a role in ruling out SNTB in this population. Prospective validation of this model is needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22748017     DOI: 10.5588/ijtld.11.0743

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Impact of mycobacterial culture among HIV-infected adults with presumed TB in Uganda: a prospective cohort study.

Authors:  F C Semitala; L H Chaisson; S den Boon; N Walter; A Cattamanchi; M Awor; J Katende; L Huang; M Joloba; H Albert; M R Kamya; J L Davis
Journal:  Public Health Action       Date:  2015-05-08

2.  Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa.

Authors:  P K Drain; L Mayeza; P Bartman; R Hurtado; P Moodley; S Varghese; G Maartens; G G Alvarez; D Wilson
Journal:  Int J Tuberc Lung Dis       Date:  2014-01       Impact factor: 2.373

3.  Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV.

Authors:  Christina Yoon; J Lucian Davis; Laurence Huang; Conrad Muzoora; Helen Byakwaga; Colin Scibetta; David R Bangsberg; Payam Nahid; Fred C Semitala; Peter W Hunt; Jeffrey N Martin; Adithya Cattamanchi
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

4.  Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis.

Authors:  S D Lawn; A D Kerkhoff; M Vogt; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2013-05       Impact factor: 2.373

5.  A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.

Authors:  Selena Ferrian; Claudia Manca; Sugnet Lubbe; Francesca Conradie; Nazir Ismail; Gilla Kaplan; Clive M Gray; Dorothy Fallows
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

6.  Clinical predictors of pulmonary tuberculosis among South African adults with HIV.

Authors:  Simon C Mendelsohn; Andrew Fiore-Gartland; Denis Awany; Humphrey Mulenga; Stanley Kimbung Mbandi; Michèle Tameris; Gerhard Walzl; Kogieleum Naidoo; Gavin Churchyard; Thomas J Scriba; Mark Hatherill
Journal:  EClinicalMedicine       Date:  2022-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.